Manuel
Barreiro de Acosta
Instituto Maimónides de Investigación Biomédica de Córdoba
Córdoba, EspañaPublicacións en colaboración con investigadores/as de Instituto Maimónides de Investigación Biomédica de Córdoba (3)
2024
-
Clinical and treatment outcomes of a second subcutaneous or intravenous anti-TNF in patients with ulcerative colitis treated with two consecutive anti-TNF agents: data from the ENEIDA registry
Therapeutic Advances in Gastroenterology, Vol. 17
2022
2019
-
The combination of granulocyte-monocyte apheresis and vedolizumab: A new treatment option for ulcerative colitis?
Journal of Clinical Apheresis, Vol. 34, Núm. 6, pp. 680-685